Japan Sepsis Diagnostics Market Size & Outlook, 2026-2033
- Clinical Diagnostics
- In Vitro Diagnostics
- Sepsis Diagnostics Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask Prism AI about the sepsis diagnostics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Japan sepsis diagnostics market highlights
- The Japan sepsis diagnostics market generated a revenue of USD 56.1 million in 2025 and is expected to reach USD 124.2 million by 2033.
- The Japan market is expected to grow at a CAGR of 10.5% from 2026 to 2033.
- In terms of segment, conventional diagnostics was the largest revenue generating method in 2025.
- Automated Diagnostics is the most lucrative method segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2025 | USD 56.1 million |
| Market revenue in 2033 | USD 124.2 million |
| Growth rate | 10.5% (CAGR from 2026 to 2033) |
| Largest segment | Conventional diagnostics |
| Fastest growing segment | Automated Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Diagnostics, Conventional Diagnostics |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Japan accounted for 4.5% of the global sepsis diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 99.3 million by 2033.
Japan faces a significant burden of sepsis, largely due to its aging population and increasing prevalence of chronic diseases. Sepsis remains a leading cause of mortality in Japanese hospitals, emphasizing the urgent need for effective diagnostic solutions.
Approval and launch of novel sepsis diagnostic tests, coupled with supportive reimbursement scenarios, are expected to support market growth. For instance, in August 2018, Sysmex Corporation, a Japanese healthcare company, launched its new HISCL Presepsin Assay Kit for Sepsis Testing.
In March 2024, the Tokyo Metropolitan Government issued a warning as cases of Streptococcal Toxic Shock Syndrome (STSS), a severe and rare bacterial infection, have surged. This year, reported cases in Tokyo have already surpassed half of last year’s total, reaching 88 infections in the capital alone, with a national tally of 517 cases.
No credit card required*
Publish Date: Jun 10, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Koninklijke Philips NV | View profile | 73,712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | www.philips.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Luminex | View profile | 501-1000 | Austin, Texas, United States, North America | www.luminexcorp.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| Immunexpress | View profile | 11-50 | Seattle, Washington, United States, North America | www.immunexpress.com |
Japan Sepsis Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Sepsis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Conventional Diagnostics was the largest segment with a revenue share of 63.64% in 2025.
Horizon Databook has segmented the Japan sepsis diagnostics market based on automated diagnostics, conventional diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
Japan faces a significant burden of sepsis, largely due to its aging population and increasing prevalence of chronic diseases. Sepsis remains a leading cause of mortality in Japanese hospitals, emphasizing the urgent need for effective diagnostic solutions.
Approval and launch of novel sepsis diagnostic tests, coupled with supportive reimbursement scenarios, are expected to support market growth. For instance, in August 2018, Sysmex Corporation, a Japanese healthcare company, launched its new HISCL Presepsin Assay Kit for Sepsis Testing.
In March 2024, the Tokyo Metropolitan Government issued a warning as cases of Streptococcal Toxic Shock Syndrome (STSS), a severe and rare bacterial infection, have surged. This year, reported cases in Tokyo have already surpassed half of last year’s total, reaching 88 infections in the capital alone, with a national tally of 517 cases.
- Japan Sepsis Diagnostics Market Method Outlook (Revenue, USD Million , 2021-2033)
- Automated Diagnostics
- Conventional Diagnostics
- Japan Sepsis Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Immunoassays
- Others
- Microbiology
- Flow Cytometry
- Molecular Diagnostics
- Japan Sepsis Diagnostics Market Pathogen Outlook (Revenue, USD Million , 2021-2033)
- Bacterial Sepsis
- Fungal Sepsis
- Viral Sepsis and Others
- Japan Sepsis Diagnostics Market Testing Type Outlook (Revenue, USD Million , 2021-2033)
- Laboratory Testing
- Point-of-Care Testing
- Japan Sepsis Diagnostics Market End User Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Clinics
- Pathology & Reference Laboratories
- Research Institutes and Others
- Japan Sepsis Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Blood Culture Media
- Assay Kits & Reagents
- Software
Reasons to subscribe to Sepsis Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sepsis Diagnostics Market Outlook databook
- Our clientele includes a mix of Sepsis Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Sepsis Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Sepsis Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Sepsis Diagnostics Market, 2021-2033 (US$M)
Japan sepsis diagnostics market statistics, by method, 2021-2033 (US$M)
